Log In or Register to Join The Conversation!
  • This topic is empty.
Viewing 0 reply threads
  • Author
    Posts
    • #19726

      Data from a long-term extension of a Phase 2 trial show oral evobrutinib taken for up to 108 weeks led to sustained reductions in relapse rates. Read more here.

      What do you think of this news?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.
Copyright © 2017-2020 All rights reserved.

©2020 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account